Clearance of cardiac troponin T with and without kidney function

Clinical Biochemistry

Volumn 50, Issue 9, 2017, Pages 468-474

  Fridén, Vincent ^a   Starnberg, Karin ^a   Muslimovic, Aida ^a   Ricksten, Sven Erik ^a   Bjurman, Christian ^a   Forsgard, Niklas ^a   Wickman, Anna ^a   Hammarsten, Ola ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cardiac troponin T; Kidney dependent clearance; Myocardial infarction

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BIOLOGICAL MARKER; CREATININE; HEART MUSCLE EXTRACT; MYOGLOBIN; SODIUM; THYROGLOBULIN; TROPONIN T;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; GLOMERULUS BASEMENT MEMBRANE; HEART FAILURE; HEART INFARCTION; HEART TISSUE; HUMAN; KIDNEY BLOOD VESSEL; KIDNEY FUNCTION; KIDNEY VEIN; MAJOR CLINICAL STUDY; MALE; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RAT; RECEIVER OPERATING CHARACTERISTIC; RENAL CLEARANCE; SODIUM BLOOD LEVEL; STEADY STATE; VASCULAR CLAMP; VEIN CATHETERIZATION; ANIMAL; CARDIAC MUSCLE; GLOMERULUS FILTRATION RATE; METABOLISM; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; GLOMERULAR BASEMENT MEMBRANE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTEOLYSIS; RATS; RATS, SPRAGUE-DAWLEY; TROPONIN T;

EID: 85013096166     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2017.02.007     Document Type: Article

References (37)

1. Thygesen, K., Alpert, J.S., Jaffe, A.S., Simoons, M.L., Chaitman, B.R., White, H.D., et al. Third universal definition of myocardial infarction. Circulation 126 (2012), 2020–2035.
2. Hammarsten, O., Fu, M.L., Sigurjonsdottir, R., Petzold, M., Said, L., Landin-Wilhelmsen, K., Troponin T percentiles from a random population sample, emergency room patients and patients with myocardial infarction. Clin. Chem. 58 (2012), 628–637.
3. Reiter, M., Twerenbold, R., Reichlin, T., Haaf, P., Peter, F., Meissner, J., et al. Early diagnosis of acute myocardial infarction in the elderly using more sensitive cardiac troponin assays. Eur. Heart J. 32 (2011), 1379–1389.
4. Eggers, K.M., Jaffe, A.S., Venge, P., Lindahl, B., Clinical implications of the change of cardiac troponin I levels in patients with acute chest pain - an evaluation with respect to the universal definition of myocardial infarction. Clin. Chim. Acta 412 (2011), 91–97.
5. Reichlin, T., Irfan, A., Twerenbold, R., Reiter, M., Hochholzer, W., Burkhalter, H., et al. Utility of absolute and relative changes in cardiac troponin concentrations in the early diagnosis of acute myocardial infarction. Circulation 124 (2011), 136–145.
6. Maisel, A., Mueller, C., Neath, S.X., Christenson, R.H., Morgenthaler, N.G., McCord, J., et al. Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (copeptin helps in the early detection of patients with acute myocardial INfarction). J. Am. Coll. Cardiol. 62 (2013), 150–160.
7. Hasegawa, M., Ishii, J., Kitagawa, F., Kanayama, K., Takahashi, H., Ozaki, Y., Yuzawa, Y., Prognostic value of highly sensitive troponin T on cardiac events in patients with chronic kidney disease not on dialysis. Heart Vessel. 28 (2013), 473–479.
8. Omland, T., de Lemos, J.A., Sabatine, M.S., Christophi, C.A., Rice, M.M., Jablonski, K.A., et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N. Engl. J. Med. 361 (2009), 2538–2547.
9. Eggers, K.M., Lind, L., Ahlstrom, H., Bjerner, T., Ebeling Barbier, C., Larsson, A., et al. Prevalence and pathophysiological mechanisms of elevated cardiac troponin I levels in a population-based sample of elderly subjects. Eur. Heart J. 29 (2008), 2252–2258.
10. Kelley, W.E., Januzzi, J.L., Christenson, R.H., Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure. Clin. Chem. 55 (2009), 2098–2112.
11. Giannitsis, E., Katus, H.A., Cardiac troponin level elevations not related to acute coronary syndromes. Nat. Rev. Cardiol. 10 (2013), 623–634.
12. deFilippi, C., Seliger, S.L., Kelley, W., Duh, S.H., Hise, M., Christenson, R.H., et al. Interpreting cardiac troponin results from high-sensitivity assays in chronic kidney disease without acute coronary syndrome. Clin. Chem. 58 (2012), 1342–1351.
13. Bjurman, C., Petzold, M., Venge, P., Farbemo, J., Fu, M.L., Hammarsten, O., High-sensitive cardiac troponin, NT-proBNP, hFABP and copeptin levels in relation to glomerular filtration rates and a medical record of cardiovascular disease. Clin. Biochem. 48 (2015), 302–307.
14. Palazzuoli, A., Masson, S., Ronco, C., Maisel, A., Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin. Heart Fail. Rev. 19 (2014), 267–284.
15. Dunn, M.E., Coluccio, D., Hirkaler, G., Mikaelian, I., Nicklaus, R., Lipshultz, S.E., et al. The complete pharmacokinetic profile of serum cardiac troponin I in the rat and the dog. Toxicol. Sci. 123 (2011), 368–373.
16. Norden, A.G., Lapsley, M., Lee, P.J., Pusey, C.D., Scheinman, S.J., Tam, F.W., et al. Glomerular protein sieving and implications for renal failure in Fanconi syndrome. Kidney Int. 60 (2001), 1885–1892.
17. Streng, A.S., de Boer, D., Bouwman, F.G., Mariman, E.C., Scholten, A., van Dieijen-Visser, M.P., Wodzig, W.K., Validation, optimisation, and application data in support of the development of a targeted selected ion monitoring assay for degraded cardiac troponin T. Data brief 7 (2016), 397–405.
18. Streng, A.S., de Boer, D., Bouwman, F.G., Mariman, E.C., Scholten, A., van Dieijen-Visser, M.P., Wodzig, W.K., Development of a targeted selected ion monitoring assay for the elucidation of protease induced structural changes in cardiac troponin T. J. Proteome 136 (2016), 123–132.
19. Cardinaels, E.P., Mingels, A.M., van Rooij, T., Collinson, P.O., Prinzen, F.W., van Dieijen-Visser, M.P., Time-dependent degradation pattern of cardiac troponin T following myocardial infarction. Clin. Chem. 59 (2013), 1083–1090.
20. Ziebig, R., Lun, A., Hocher, B., Priem, F., Altermann, C., Asmus, G., et al. Renal elimination of troponin T and troponin I. Clin. Chem. 49 (2003), 1191–1193.
21. Wiessner, R., Hannemann-Pohl, K., Ziebig, R., Grubitzsch, H., Hocher, B., Vargas-Hein, O., et al. Impact of kidney function on plasma troponin concentrations after coronary artery bypass grafting. Nephrol. Dial. Transplant. 23 (2008), 231–238.
22. Ellis, K., Dreisbach, A.W., Lertora, J.L., Plasma elimination of cardiac troponin I in end-stage renal disease. South. Med. J. 94 (2001), 993–996.
23. Fredericks, S., Chang, R., Gregson, H., Bewick, M., Collinson, P.O., Gaze, D., et al. Circulating cardiac troponin-T in patients before and after renal transplantation. Clin. Chim. Acta 310 (2001), 199–203.
24. Sward, K., Valsson, F., Sellgren, J., Ricksten, S.E., Bedside estimation of absolute renal blood flow and glomerular filtration rate in the intensive care unit. A validation of two independent methods. Intensive Care Med. 30 (2004), 1776–1782.
25. Nyman, U., Grubb, A., Lindstrom, V., Bjork, J., Accuracy of GFR estimating equations in a large Swedish cohort: implications for radiologists in daily routine and research. Acta Radiol. 58 (2017), 367–375.
26. Hallgren, R., Karlsson, F.A., Roxin, L.E., Venge, P., Myoglobin turnover-influence of renal and extrarenal factors. J. Lab. Clin. Med. 91 (1978), 246–254.
27. Lappalainen, H., Tiula, E., Uotila, L., Manttari, M., Elimination kinetics of myoglobin and creatine kinase in rhabdomyolysis: implications for follow-up. Crit. Care Med. 30 (2002), 2212–2225.
28. Wakabayashi, Y., Kikuno, T., Ohwada, T., Kikawada, R., Rapid fall in blood myoglobin in massive rhabdomyolysis and acute renal failure. Intensive Care Med. 20 (1994), 109–112.
29. Pluddemann, A., Neyen, C., Gordon, S., Macrophage scavenger receptors and host-derived ligands. Methods 43 (2007), 207–217.
30. Goldstein, J.L., Brown, M.S., Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249 (1974), 5153–5162.
31. Schneider, W.J., Beisiegel, U., Goldstein, J.L., Brown, M.S., Purification of the low density lipoprotein receptor, an acidic glycoprotein of 164,000 molecular weight. J. Biol. Chem. 257 (1982), 2664–2673.
32. Smit, M.J., Duursma, A.M., Bouma, J.M., Gruber, M., Receptor-mediated endocytosis of lactate dehydrogenase M4 by liver macrophages: a mechanism for elimination of enzymes from plasma. Evidence for competition by creatine kinase MM, adenylate kinase, malate, and alcohol dehydrogenase. J. Biol. Chem. 262 (1987), 13020–13026.
33. Takashio, S., Yamamuro, M., Izumiya, Y., Sugiyama, S., Kojima, S., Yamamoto, E., et al. Coronary microvascular dysfunction and diastolic load correlate with cardiac troponin T release measured by a highly sensitive assay in patients with nonischemic heart failure. J. Am. Coll. Cardiol. 62 (2013), 632–640.
34. Grubb, A., Horio, M., Hansson, L.O., Bjork, J., Nyman, U., Flodin, M., et al. Generation of a new cystatin C-based estimating equation for glomerular filtration rate by use of 7 assays standardized to the international calibrator. Clin. Chem. 60 (2014), 974–986.
35. Chow, M.S., A method for determining the pharmacokinetics of endogenous creatinine without exogenous creatinine administration. Biopharm. Drug Dispos. 6 (1985), 201–208.
36. Roysland, R., Kravdal, G., Hoiseth, A.D., Nygard, S., Badr, P., Hagve, T.A., et al. Cardiac troponin T levels and exercise stress testing in patients with suspected coronary artery disease: the Akershus Cardiac Examination (ACE) 1 study. Clin. Sci. 122 (2012), 599–606.
37. Sou, S.M., Puelacher, C., Twerenbold, R., Wagener, M., Honegger, U., Reichlin, T., et al. Direct comparison of cardiac troponin I and cardiac troponin T in the detection of exercise-induced myocardial ischemia. Clin. Biochem. 49 (2016), 421–432.